Avantor, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Avantor, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.55B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $6.78B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $6.97B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $7.51B | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $7.39B | Feb 14, 2024 |
| FY2020 | Dec 31, 2020 | $1.79B | Feb 16, 2021 |
| FY2020 | Sep 30, 2020 | $1.61B | Feb 16, 2021 |
| FY2020 | Jun 30, 2020 | $1.48B | Feb 16, 2021 |
| FY2020 | Mar 31, 2020 | $1.52B | Feb 16, 2021 |
| FY2020 | Dec 31, 2019 | $1.52B | Feb 16, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.14B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $2.28B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $2.36B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $2.60B | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $2.50B | Feb 14, 2024 |
| FY2020 | Dec 31, 2020 | $581.60M | Feb 16, 2021 |
| FY2020 | Sep 30, 2020 | $506.40M | Feb 16, 2021 |
| FY2020 | Jun 30, 2020 | $490.60M | Feb 16, 2021 |
| FY2020 | Mar 31, 2020 | $501.90M | Feb 16, 2021 |
| FY2020 | Dec 31, 2019 | $480.40M | Feb 16, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($530.20M) | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $711.50M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $321.10M | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $686.50M | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $572.60M | Feb 14, 2024 |
| FY2020 | Dec 31, 2020 | $51.60M | Feb 16, 2021 |
| FY2020 | Sep 30, 2020 | ($42.20M) | Feb 16, 2021 |
| FY2020 | Jun 30, 2020 | $60.20M | Feb 16, 2021 |
| FY2020 | Mar 31, 2020 | $47.00M | Feb 16, 2021 |
| FY2020 | Dec 31, 2019 | $70.60M | Feb 16, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($246.20M) | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $1.08B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $696.40M | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $1.13B | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $972.20M | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $706.80M | Feb 14, 2023 |
| FY2020 | Dec 31, 2019 | $551.80M | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $413.50M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | ($210.40M) | Feb 14, 2020 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.60B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $1.64B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $1.51B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $1.47B | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $1.53B | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $1.37B | Feb 14, 2023 |
| FY2020 | Dec 31, 2019 | $1.37B | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $1.41B | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $449.70M | Feb 14, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $623.80M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $840.80M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $870.00M | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $843.60M | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $953.60M | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $929.80M | Feb 14, 2023 |
| FY2020 | Dec 31, 2019 | $354.00M | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $200.50M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | ($167.50M) | Feb 14, 2020 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $128.80M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $148.80M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $146.40M | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $133.40M | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $111.10M | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $61.60M | Feb 14, 2023 |
| FY2020 | Dec 31, 2019 | $51.60M | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $37.70M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $25.20M | Feb 14, 2020 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.79B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $12.11B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $12.97B | Feb 7, 2025 |
| FY2023 | Dec 31, 2022 | $13.46B | Feb 14, 2024 |
| FY2022 | Dec 31, 2021 | $13.90B | Feb 14, 2023 |
| FY2020 | Dec 31, 2020 | $9.91B | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | $9.77B | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $9.91B | Feb 14, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.23B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $6.16B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $7.72B | Feb 7, 2025 |
| FY2023 | Dec 31, 2022 | $8.61B | Feb 14, 2024 |
| FY2022 | Dec 31, 2021 | $9.70B | Feb 14, 2023 |
| FY2020 | Dec 31, 2020 | $7.23B | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | $7.31B | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $9.10B | Feb 14, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.57B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $5.96B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $5.25B | Feb 11, 2026 |
| FY2025 | Dec 31, 2022 | $4.86B | Feb 11, 2026 |
| FY2024 | Dec 31, 2021 | $4.20B | Feb 7, 2025 |
| FY2023 | Dec 31, 2020 | $2.67B | Feb 14, 2024 |
| FY2022 | Dec 31, 2019 | $2.46B | Feb 14, 2023 |
| FY2020 | Dec 31, 2018 | ($3.05B) | Feb 11, 2022 |
| FY2020 | Dec 31, 2017 | ($2.62B) | Feb 16, 2021 |
| FY2019 | Dec 31, 2016 | ($510.60M) | Feb 14, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.99B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $5.54B | Feb 11, 2026 |
| FY2025 | Jan 1, 2024 | $5.72B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $5.72B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $5.65B | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $5.34B | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $2.86B | Feb 14, 2023 |
| FY2020 | Dec 31, 2019 | $2.77B | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $2.78B | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $2.85B | Feb 14, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.67B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $2.20B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $1.49B | Feb 7, 2025 |
| FY2023 | Dec 31, 2022 | $1.17B | Feb 14, 2024 |
| FY2022 | Dec 31, 2021 | $483.90M | Feb 14, 2023 |
| FY2020 | Dec 31, 2020 | ($88.70M) | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | ($203.70M) | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | ($238.40M) | Feb 14, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $365.40M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $261.90M | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $262.90M | Feb 7, 2025 |
| FY2023 | Dec 31, 2022 | $372.90M | Feb 14, 2024 |
| FY2022 | Dec 31, 2021 | $301.70M | Feb 14, 2023 |
| FY2020 | Dec 31, 2020 | $286.60M | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | $186.70M | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $184.70M | Feb 14, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.95B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $4.06B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $5.54B | Feb 7, 2025 |
| FY2023 | Dec 31, 2022 | $6.29B | Feb 14, 2024 |
| FY2022 | Dec 31, 2021 | $7.02B | Feb 14, 2023 |
| FY2020 | Dec 31, 2020 | $4.89B | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | $5.12B | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $6.92B | Feb 14, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 14, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 16, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 16, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 16, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 16, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 16, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 14, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 16, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 16, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 16, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 16, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 16, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 682.00M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 680.80M | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | 676.60M | Feb 7, 2025 |
| FY2023 | Dec 31, 2022 | 674.30M | Feb 14, 2024 |
| FY2022 | Dec 31, 2021 | 609.70M | Feb 14, 2023 |
| FY2020 | Dec 31, 2020 | 580.10M | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | 572.80M | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | 132.80M | Feb 14, 2020 |